Julia Bonavitacola

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Adults can undergo CAR T-cell therapy for relapsed or refractory mantle cell lymphoma after the full approval of the treatment.

The US has seen approximately 370 cases of mpox through March 2026, indicating a consistent need to diagnose the illness.

Lower actual wearable use was found in patients with multiple sclerosis (MS) despite comparable intentions to use the wearable technology.

There were few incidences of complications in the follow-up period after the MicroShunt was implanted in the patient.

TrumpRx launched in early February with the aim to offer lower-priced drugs to those without insurance or those who would like to pay in cash. The results are more complicated.

The study, evaluating the efficacy of the combination of efgartigimod alfa and hyaluronidase-qvfc, is the first to specifically evaluate those with ocular myasthenia gravis.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The incidence of very late onset of myasthenia gravis has increased in the past 50 years, which has had implications on prognosis.

Increased health care costs, use of nonsteroidal immunosuppressants, and elevated health care costs were associated with use of glucocorticoids by patients with myasthenia gravis.

Smoking cessation, abnormal weight, and socioeconomic deprivation were all associated with mortality in multiple sclerosis.

The prevalence of retinal conditions in the US varied by region, race and ethnicity, and sex, which could identify areas of need.

Maria Hordinsky, MD, discusses the promise of Janus kinase (JAK) inhibitors in treating alopecia areata in the long term.

Maria Hordinsky, MD, discusses exciting results in alopecia areata, including some discussed at the Winter Clinical Dermatology Conference.

Disparities in health system performance were larger by income in the US, indicating a need for structural and systemic policy efforts.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A survey of marketplace enrollees revealed that they expect to cut back on basic household expenses to keep insurance coverage.

Patients with primary biliary cholangitis (PBC) can use linerixibat to address cholestatic pruritus, which up to 89% of patients with PBC experience.

Patients with multiple sclerosis valued both occupational therapy and physiotherapy as means of addressing their condition.

The complete response letter marks the second time that reproxalap, a medication for use in dry eye disease, has been rejected by the FDA.

Severe COVID-19 was rare in patients with multiple sclerosis even when vaccine responses were impaired.

Legislation that passed the Senate will introduce reform in how pharmacy benefit managers are addressed by CMS starting in 2028.

The website officially launched on February 5, introducing a key part of the Trump administration’s health care plan.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Experts discussed how systemic changes need to be made to help improve preventive care access, which in turn can improve outcomes.

Lindsey Dawson, MA, speaks about how budget decisions regarding ADAPs in Florida could affect patients with HIV should these decisions be made permanent.

Short-term anatomical and visual improvements were found when patients used SB15 to treat their macular edema caused by retinal vein occlusion (RVO).

Cardiovascular disease is the leading cause of death in North Carolina, and effective management of the condition is essential to improving residents’ quality of life.

Persistent high-level EBNA-1 peptide antibody titers could be used to identify multiple sclerosis (MS) vs neuromyelitis optica spectrum disorder (NMOSD).

The efficacy and safety of efgartigimod in pediatric patients will need to be further validated with future studies.